表紙
市場調查報告書
商品編碼
392822

全球無塵室技術市場:市場趨勢與預測

Cleanroom Technology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球無塵室技術市場相關調查分析,市場區隔,全球/各地區的市場分析,市場影響要素,市場機會,主要企業,競爭情形等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 主要推論

第5章 市場概要

  • 簡介
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 波特的五力分析
  • 價值鏈分析

第6章 市場區隔:各零件

  • 設備的各類型
  • 消耗品的各類型

第7章 市場區隔:各建設類型

  • 硬質牆無塵室
  • 軟質牆無塵室
  • 終端箱/穿牆櫃
  • 標準/乾式牆無塵室

第8章 市場區隔:各終端用戶產業

  • 醫藥品
  • 生物科技
  • 醫院
  • 醫療設備
  • 半導體製造
  • 食品產業
  • 其他

第9章 市場區隔:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

第11章 投資分析

第12章 企業簡介

  • Royal Imtech N.V
  • Azbil Corporation
  • 大氣社
  • Kimberly-Clark Corporation
  • Ardmac, Ltd
  • Ansell Healthcare
  • Clean Air Products
  • Illinois Tool Works, Inc.
  • M+W Group GmbH
  • Supermax Corporation Berhad
  • Hartalega Holdings Berhad
  • Alpiq Group

第13章 無塵室技術市場未來

目錄
Product Code: 56224

The cleanroom technology market was valued at USD 6.454 billion in 2020 and expected to reach a value of USD 8.87 billion by 2026, at a CAGR of 5.45% over the forecast period (2021 - 2026). Furthermore, the outbreak of the COVID-19 pandemic across the world affected more than 3.9 million people as of May 8, 2020, according to Worldometers, which has enabled a surge in laboratory activities. The pandemic has forced the activity of sample collections and testing of the people affected with the pandemic virus, which has, in turn, forced the demand for consumables in the cleanroom environment.

Key Highlights

  • Also, the market is witnessing rising research activities in the drive to develop a vaccine for the pandemic virus. For instance, in April 2020, BioNTech SE announced that the German regulatory authority, the Paul-Ehrlich-Institute, has approved the Phase I/II clinical trial for the company's BNT162 vaccine program to prevent COVID-19 infection. Such initiatives are expected to accentuate the demand for cleanroom consumables.
  • The cleanroom technology market has earned some encouraging strides on the back of the adoption of cleanrooms in manufacturing environments. Regulatory constraints and consumer requirements for better quality products in these environments have augmented the steady evolution of the market.
  • The market is witnessing a rise in investments from the government agencies and private organizations to finance the R&D activities in small companies striving to advance their initial discoveries to commercial development. For instance, the Department of Health and Human Services' Small Business Innovation Research and Small Business Technology Transfer programs offer financial assistance to small companies endeavoring to advance their initial discoveries to commercial development. ​
  • Sectors that demand cleanroom environments had made influential manufacturing expansions in 2019 and cleanroom developers have taken part in multimillion-dollar projects for space, pharmaceutical, hi-tech, and industrial production.​
  • The majority of builds observed in the pharmaceutical sector in 2019 were in Europe and the United States. Ireland has been a special place of interest for construction and is considered a strategic location for companies during the upcoming withdrawal of the United Kingdom from the European Union.​
  • For instance, WHP Engineering has been profoundly involved with the biotherapeutics industry. In the middle of 2019, the United Kingdom-based company completed a USD 6.7 million agreement with ADC Bio for its Welsh manufacturing plant, which produces antibody-drug conjugates.​

Key Market Trends

Pharmaceutical Industry to Witness Significant Growth

  • The cleanroom technology market has earned some encouraging strides on the back of the adoption of cleanrooms in manufacturing environments. Regulatory constraints and consumer requirements for better quality products in these environments have augmented the steady evolution of the market.
  • The majority of builds observed in the pharmaceutical sector in 2019 were in Europe and the United States. Ireland has been a special place of interest for construction and is considered a strategic location for companies during the upcoming withdrawal of the United Kingdom from the European Union.​
  • For instance, WHP Engineering has been profoundly involved with the biotherapeutics industry. In the middle of 2019, the United Kingdom-based company completed a USD 6.7 million agreement with ADC Bio for its Welsh manufacturing plant, which produces antibody-drug conjugates.
  • An expanding sector of the biotherapeutics industry is cell and gene therapy. Demand is progressing in this new type of medicine, and WHP also signed an agreement with Oxford BioMedical for its new viral vector manufacturing center in England.​
  • The market studied is anticipated to benefit from the growth and investments of the pharmaceutical CDMOs. For instance, CDMOs WuXi and Cambrex have both invested in cleanroom capacity. WuXi invested USD 240 million to construct a new vaccine manufacturing facility in Ireland. Located in the WuXi Biologics Campus, the plant is anticipated to start commercial manufacturing in 2021.

North America to Hold a Significant Market Share

  • North America accounted for the most significant share, primarily owing to the presence of a large number of medical devices, pharmaceutical manufacturers, and biotechnological labs that are the primary users of cleanroom technology.
  • Among the countries of North America, the United States occupies a significant share of the market. At the same time, Canada is expected to witness the fastest growth rate in this region over the next five years.
  • The region is witnessing an increase in investments from the government agencies and private organizations to finance the R&D activities in small companies. Initiatives are taking place at the state level as well, which are expected to generate the demand for cleanroom technologies.
  • The Texas Emerging Technology Fund, for example, is explicitly intended to help companies finance proof-of-concept research. The fund finances in biologic sciences and biotechnology, as well as engineering, materials science, and information technology, and it has committed funding to individual companies with an investment ranging from USD 500,000 to USD 10 million.​
  • In November 2020, Carter Capital Partners, a Grand Rapids, Michigan-based investment bank, announced that its client, Angstrom Technology, an industry vendor in modular cleanroom production, was acquired by ASGARD Partners & Co., a New York-based private equity firm. While ASGARD has acquired the company's controlling interest, current management would remain a significant minority investor, as the company enters its next phase of growth. Charter Capital Partners principals served as the exclusive M&A advisor to Angstrom Technology.

Competitive Landscape

The cleanroom technology market is moderately fragmented. The capital requirements for setting up new businesses can be prohibitively high in a few regions. Moreover, market incumbents have a considerable advantage over new entrants, particularly in gaining access to distribution channels and R&D activities. New entrants must be mindful of regular changes in manufacturing and trade regulations in the industry. New entrants can leverage economies-of-scale advantages.

  • May 2020 - Exyte AG and Univercells Technologies, which is a provider of novel biomanufacturing technologies for economic and scalable viral production, are entering into a global partnership for optimized construction of standardized and flexible GMP manufacturing facilities for vaccine development.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers/Consumers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Assessment of Impact of COVID-19 on the Industry
  • 4.4 Market Drivers
    • 4.4.1 Overall Growth in Biotechnology and Healthcare Spending in Major Markets
    • 4.4.2 Increasing Number of Safety Products and the Demand for Quality Products
  • 4.5 Market Restraints
    • 4.5.1 High Installation, Maintenance Costs, and Lack of Skilled Workforce

5 MARKET SEGMENTATION

  • 5.1 Component
    • 5.1.1 Type of Equipment
      • 5.1.1.1 Cleanroom Air Showers
      • 5.1.1.2 HVAC Systems
      • 5.1.1.3 Laminar Air Flow Systems
      • 5.1.1.4 High Efficiency Filters
      • 5.1.1.5 Desiccator Cabinets
      • 5.1.1.6 Fan Filter Units
    • 5.1.2 Type of Consumable
      • 5.1.2.1 Apparels
      • 5.1.2.2 Gloves
      • 5.1.2.3 Wipes
      • 5.1.2.4 Vacuum Systems
      • 5.1.2.5 Disinfectants
      • 5.1.2.6 Other Types of Consumables
  • 5.2 End User
    • 5.2.1 Pharmaceutical
    • 5.2.2 Biotechnology
    • 5.2.3 Medical Devices
    • 5.2.4 Hospitals
    • 5.2.5 Semiconductor Manufacturing
    • 5.2.6 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia Pacific
    • 5.3.4 Rest of the World (Latin America and Middle East and Africa)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles*
    • 6.1.1 M+W Group GmbH
    • 6.1.2 Azbil Corporation
    • 6.1.3 Taikisha Global Limited
    • 6.1.4 Kimberly Clark Corporation
    • 6.1.5 Ardmac Ltd
    • 6.1.6 Ansell Limited
    • 6.1.7 Clean Air Products
    • 6.1.8 Labconco Corporation

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET